ICMR removes Ivermectin and Hydroxycholoquine (HCQ) from Covid-19 treatment guidelines

By Sumit Blogs -

The Indian Council of Medical Research (ICMR) has removed usage of popular drugs Ivermectin and Hydroxycholoquine (HCQ) from the approved Covid-19 treatment guidelines.

Experts at India’s health research body did not find enough evidence for Ivermectin and HCQ of a potential therapeutic effect against Covid-19, Samiran Panda head of epidemiology and infectious diseases at ICMR told ET.

“A lot of discussions took place and the experts finally came to the conclusion that there is not enough evidence that prove the effectiveness of both the drugs and hence decided to drop them from the clinical guidance for management of Covid-19 patients,” Panda said.

Earlier in May, the Union Health Ministry and Family Welfare’s directorate general of health services (DGHS) had issued comprehensive guidelines to stop the use of Ivermectin and HCQ along with many other drugs from Covid-19 treatment. However, the guidelines were not endorsed by the ICMR then as there seemed to be a split in opinion among the experts at the DGHS and the ICMR.

The DGHS guidelines however were lauded by the WHO. “Evidence-based guidelines from @mohfw DGHS – simple, rational and clear guidance for physicians. Should be translated and disseminated in all Indian languages. Can be updated as and when new evidence becomes available,” Soumya Swaminathan, Chief Scientist, World Health Organization (WHO) had tweeted then.

The WHO has also been warning against the use of Ivermectin.

Companies like Cipla, Sun Pharmaceuticals and Zuventus have popular Ivermectin brands in the market.

Ivermectin, is used to treat parasitic infections. However, it took prominence in 2020 when the doctors started prescribing it for treatment of Covid-19 jacking up its sales to manifolds. The FDA, too, had warned against its use for Covid prevention or treatment.

The National Task force of the ICMR also found that there was no strong evidence to support the use of Hydroxychloroquine (HCQ), touted as a wonder drug- in the treatment of Covid-19 and hence decided to remove it from the clinical management guidelines.

Credits – Source – https://ift.tt/2ZfrYjx

The post ICMR removes Ivermectin and Hydroxycholoquine (HCQ) from Covid-19 treatment guidelines appeared first on Stay in Gurgaon.

Comments

Post a Comment

Popular posts from this blog

Flat sale of flu drugs hints at no unusual rise in infections

By Sumit Blogs -
Image
By Economic Times – Flat sale of flu drugs hints at no unusual rise in infections Industry executives and chemists said the April sales data showed a month-on-month decline of 30-40%. But even though the lockdown is seen to be impacting sales of most drugs, the pattern for medicines for infections and flus is no different.Last Updated: Apr 30, 2020, 11.23 AM ISTAgenciesExperts said the decline in sales was primarily because of the lockdown and other restrictions which forced people to stay indoors. (This story originally appeared in on Apr 30, 2020)NEW DELHI: Sales of anti-infectives (antibiotics and antivirals), respiratory drugs, painkillers and analgesics — some key medicines used for influenza-like illnesses — have remained mostly unchanged in last three months (January to March), partly explained by the lockdown but also indicating no unusual rise in flu-type infections that might point to a wider and undetected spread of Covid-19. Sales of most medicines, including this set of
Read more

10YearsForSimha: Reasons behind film’s success

By Sumit Blogs -
Image
By Times of India – 10YearsForSimha: Reasons behind film’s success TIMESOFINDIA.COM | Last updated on – Apr 30, 2020, 06:00 ISTclose01/6Take a look at the reasons behind the film’s successDirected by Boyapati Srinu, the 2010 film Simha was a game-changer among Tollywood films that was lauded, not only for Nandamuri Balakrishna’s intense performance in the dual role but also the gripping narration of the filmmaker. Balayya and Nayanthara were seen on the big screen for the first time ever in the film. The action drama made a special place in the hearts of the audience because of its simple storytelling, superhit songs and unbeatable chemistry between the lead pair. The movie has completed a decade, but the essence is as fresh as it was back then. As the film clocks 10 years of its release, find out the reasons behind the massive success of the Balakrishna starrer.readmore02/6​Boyapati Srinu’s gripping narrationBefore Simha, Boyapati Srinu had delivered Bhadra (2005) and Tulasi (2007),
Read more

Hrithik-Saif’s Vikram Vedha hits a roadblock

By Sumit Blogs -
Image
The stage was about to be set for Hrithik Roshan and Saif Ali Khan’s ‘Vikram Vedha’ in Mumbai’s Film City. The material had reached. The artisans had been hired. But the lights have now been dimmed. Madhavan and Vijay Sethupathi’s hit movie Vikram Vedha’s Hindi remake will not go on floors by mid-July as per the original plan. The new delta virus of COVID has sent shudders down many spines and many films which were being laid out on an expansive scale have been either held back or shifted their shoots abroad. The first schedule of this Hrithik-Saif movie will now be shot abroad. A source says, “The Mumbai schedule will be done but later.” Adds the source, “It’s a call that was taken yesterday. It wasn’t an easy call to take, no doubt, but the fact that it’s going to be a costly set made the makers take the safer route rather than be sorry later.” When contacted, General Secretary of FWICE (Federation of Western India Cine Employees), Ashok Dubey, confirmed that the makers of ‘V
Read more